Massachusetts Financial Services’s Dr. Reddy's Laboratories RDY Stock Holding History

Massachusetts Financial Services’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.81M	Buy	475,589 +42,204	+10%	+$569K	﹤0.01%	782
2026 Q1	$6M	Hold	433,385	–	–	﹤0.01%	747
2025 Q4	$6.08M	Buy	433,385 +2,447	+0.6%	+$34.3K	﹤0.01%	734
2025 Q3	$6.02M	Hold	430,938	–	–	﹤0.01%	706
2025 Q2	$6.48M	Buy	430,938 +112,063	+35%	+$1.6M	﹤0.01%	701
2025 Q1	$4.21M	Hold	318,875	–	–	﹤0.01%	710
2024 Q4	$5.04M	Buy	318,875 +87,100	+38%	+$1.31M	﹤0.01%	693
2024 Q3	$3.68M	Hold	231,775	–	–	﹤0.01%	686
2024 Q2	$3.53M	Hold	231,775	–	–	﹤0.01%	704
2024 Q1	$3.4M	Buy	+231,775	New	+$3.38M	﹤0.01%	698

Other funds holding RDY

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

State of New Jersey Common Pension Fund D Trenton, New Jersey $29.3B AUM 38.15% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Quadrature Capital London, United Kingdom $11.7B AUM 87.29% 1-Year Est. Return

AIM

ARGA Investment Management Stamford, Connecticut $3.92B AUM 35.93% 1-Year Est. Return

SFA

Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return

Massachusetts Financial Services's RDY Position: Q2 2026 in Review

Massachusetts Financial Services increased its Dr. Reddy's Laboratories (RDY) stake by 9.7% in Q2 2026, buying an estimated $569K and bringing the position to 475,589 shares worth $6.81M. The position accounts for ﹤0.01% of the portfolio, ranked #782.

Massachusetts Financial Services first reported a position in RDY in Q1 2024 and has held it in 10 quarters since. 101 funds tracked by Wall St. Rank hold RDY as of Q2 2026.

Massachusetts Financial Services held 475,589 shares of Dr. Reddy's Laboratories worth $6.81M as of Q2 2026.
Massachusetts Financial Services bought 42,204 Dr. Reddy's Laboratories shares in Q2 2026, an estimated $569K.
Dr. Reddy's Laboratories made up ﹤0.01% of Massachusetts Financial Services's portfolio in Q2 2026, its #782 holding.
Massachusetts Financial Services first reported a position in Dr. Reddy's Laboratories in Q1 2024 and has held it in 10 quarters since.
101 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2026.

Based on Massachusetts Financial Services's 13F filing for Q2 2026, filed 3 Aug 2026.